Chronic obstructive pulmonary disease and associated illnesses

Cite item

Full Text

Full Text

Хроническая обструктивная болезнь легких и сопутствующие заболевания. -

About the authors

A G Chuchalin


  1. Buch P., Friberg J., Scharling Н. et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur. Respir. J. 2003; 21 (6): 1012-1016.
  2. Fuso L., Incalzi R. A., Pistelli R. et al. Predicting mortality of patients for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98 (3): 272-277.
  3. Kleiger R. E. Long-term electrocardiographic monitoring of ambulatory patients with COPD. Chest 1974; 65: 483-488.
  4. Shih H. Т., Webb C. R., Conway W. A. et al. Frequency and significance of cardiac arrhythmias in COPD. Chest 1988; 94 (1): 44-48.
  5. Bittar G, Friedman H. S. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99 (6): 1-10.
  6. Salpeter S. R., Ormiston Т. M., Salpeter E. E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125 (6): 2309-2321.
  7. Incalzi R. A., Pistelli R., Cocchi A. et al. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic COPD. Chest 1990; 97 (5): 1092-1097.
  8. Cheong Т. H., Magder S., Shapiro S. et al. Cardiac arrhythmias during exercise in severe chronic obstructive pulmonary disease. Chest 1990; 97 (4): 793-797.
  9. Salpeter S., Ormiston Т., Salpeter E. Cardioselective beta-blocker use in patients with reversible airway disease. Cochrane Database Syst. Rev. 2001; (2): CD002992.
  10. Ind P. W., Dixon С. M., Fuller R. W., Barnes P. J. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am. Rev. Respir. Dis. 1989; 139 (6): 1390-1394.
  11. Behar S., Panosh A., Reicher-Reiss H. et al. Prevalence and prognosis of COPD among 5839 consecutive patients with acute myocardila infarction. Sprint Study Group. Am. J. Med. 1992; 93 (6): 637-641.
  12. Man S. F. COPD as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorax Soc. 2005; 2 (1): 8-11.
  13. Jousilahti P., Vartianen E., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348 (9027): 567-572.
  14. Triboulloy C, Rosinaru D., Mahjoub H. et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur. Heart J. 2007; 5.
  15. Dahl M., Vestbo J., Lange P. et al. C-reactive protein as a predictor of prognosis in COPD. Am. J. Respir. Crit. Med. 2007; 175: 250-255.
  16. van Vliet M., Spruit M. A., Verleden G. et al. Hypogonadism, quadriceps, weakness, and exercise intolerance in COPD. Am. J. Respir. Crit. Care Med. 2005; 172: 105-111.

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail:


© 2018-2021 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies